539 - Treatment outcomes in transarterial chemoembolization (TACE) refractory hepatocellular carcinoma patients converted to lenvatinib therapy
SIR ePoster library. Murakami K. 03/28/20; 289783; 539
Kenji Murakami
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
Poster Title: Treatment outcomes in transarterial chemoembolization (TACE) refractory hepatocellular carcinoma patients converted to lenvatinib therapy
Poster number: 539
Category: Interventional Oncology: Chemoembolization
Authors: K Murakami1, K Kamada2
Keywords: 0539, Kenji Murakami Treatment outcomes in transarterial chemoembolization (TACE) refractory hepatocellular carcinoma patients converted to lenvatinib therapy Treatment outcomes in transarterial chemoembo
Poster number: 539
Category: Interventional Oncology: Chemoembolization
Authors: K Murakami1, K Kamada2
Keywords: 0539, Kenji Murakami Treatment outcomes in transarterial chemoembolization (TACE) refractory hepatocellular carcinoma patients converted to lenvatinib therapy Treatment outcomes in transarterial chemoembo
Poster Title: Treatment outcomes in transarterial chemoembolization (TACE) refractory hepatocellular carcinoma patients converted to lenvatinib therapy
Poster number: 539
Category: Interventional Oncology: Chemoembolization
Authors: K Murakami1, K Kamada2
Keywords: 0539, Kenji Murakami Treatment outcomes in transarterial chemoembolization (TACE) refractory hepatocellular carcinoma patients converted to lenvatinib therapy Treatment outcomes in transarterial chemoembo
Poster number: 539
Category: Interventional Oncology: Chemoembolization
Authors: K Murakami1, K Kamada2
Keywords: 0539, Kenji Murakami Treatment outcomes in transarterial chemoembolization (TACE) refractory hepatocellular carcinoma patients converted to lenvatinib therapy Treatment outcomes in transarterial chemoembo
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}